Keunyoung Kim

Keunyoung Kim

Auto-generated profile, based on publicly available information

Keunyoung Kim

Pusan National University Hospital

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2023 in Thyroid®
Verified
Journal Article
Closed access
JBJi-In Bang
Ji-In Bang
SPSohyun Park
Sohyun Park
KKKeunyoung Kim
Keunyoung Kim
YSYoungduk Seo
Youngduk Seo
ACAri Chong
Ari Chong
SOSo Won Oh
So Won Oh
Background: The objective of this study is to evaluate the diagnostic accuracy of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in detecting recurrence in patients with differentiated thyroid cancer (DTC) who have negative whole-body scans (WBSs) but elevated serum thyroglobulin (Tg) or thyroglobulin antibody (TgAb) levels. Methods: This systematic review/meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis for Diagnostic Test Accuracy criteria (International Prospective Register of Systematic Reviews registration number: CRD42022340924). A comprehensive search of the MEDLINE, EMBASE, and Cochrane databases identified articles reporting the diagnostic accuracy of FDG PET/CT for the detection of recurrence in patients with DTC with negative WBS and elevated serum Tg or TgAb levels published between January 2012 and June 2023. Meta-analyses were performed to determine the diagnostic accuracy of FDG PET/CT on the total target population as well as on subgroups stratified by serum Tg or TgAb, and thyrotropin (TSH) stimulation status at the time of FDG PET/CT. The Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) framework was applied to evaluate the quality of evidence and the strength of recommendations to facilitate translation of the meta-analysis results into practical recommendations for clinical guidelines. Results: A total of 24 studies involving 1988 patients were included for analysis. The overall pooled sensitivity and specificity values were 0.87 (95% confidence interval [CI] = 0.83–0.92; I 2 = 75%) and 0.84 (CI = 0.80–0.89; I 2 = 44%), respectively. Subgroup analyses revealed no significant differences in the diagnostic accuracy of FDG PET/CT in patients stratified by serum Tg or TgAb levels, and TSH stimulation status at the time of PET/CT. Treatment plans were changed following FDG PET/CT imaging in 40% (CI = 34–47%; I 2 = 39%) of cases. The quality level of evidence for using FDG PET/CT was moderate in both sensitivity and specificity according to the GRADE system. Conclusion: There is moderate quality evidence demonstrating the high diagnostic accuracy of FDG PET/CT in detecting recurrence in patients with DTC with negative WBS and elevated serum Tg or TgAb levels. This evidence corroborates the current guidelines' endorsement of FDG PET/CT as a diagnostic tool in such patients.

1 October 2018 in Thyroid®
Verified
Journal Article
Closed access
SKSeong-Jang Kim
Seong-Jang Kim
SLSuho Lee
Suho Lee
SJShin Young Jeong
Shin Young Jeong
KPKyoungjune Pak
Kyoungjune Pak
KKKeunyoung Kim
Keunyoung Kim
Objective: The purpose of the current study was to investigate the diagnostic performance of Tc-99m methoxy-isobutyl-isonitrile (MIBI) for differentiation of malignant thyroid nodules (TN) through a systematic review and meta-analysis. Methods: The MEDLINE/PubMed and EMBASE database, from the earliest available date of indexing through January 31, 2018, were searched for studies evaluating the diagnostic performance of Tc-99m MIBI for TN. We determined the sensitivities and specificities across studies, calculated positive and negative likelihood ratios (LR+ and LR-), and constructed summary receiver operating characteristic curves. Results: Across 22 studies (2,421 patients), the pooled sensitivity for Tc-99m MIBI thyroid scan was 0.87 (95% CI; 0.76-0.93) with heterogeneity (I2=92.3) and a pooled specificity of 0.78 (95% CI; 0.67-0.86) with heterogeneity (I2=96.4). Likelihood ratio (LR) syntheses gave an overall positive likelihood ratio (LR+) of 4.0 (95% CI; 2.5-6.3) and negative likelihood ratio (LR-) of 0.17 (95% CI; 0.09-0.32). The pooled diagnostic odds ratio (DOR) was 24 (95% CI; 63-176). Hierarchical summary receiver operating characteristic (ROC) curve and indicates that the areas under the curve was 0.90 (95% CI; 0.87-0.92). In meta-regression analysis, no definite variable was the source of the study heterogeneity. Conclusion: The current meta-analysis showed the moderate sensitivity and specificity of Tc-99m MIBI thyroid scan for differentiation of malignant TN. However, the DOR was relatively low and the likelihood ratio scatter-gram indicated that Tc-99m MIBI thyroid scan is not useful for confirmation of presence of malignant TN and not for its exclusion. Therefore, cautious application and interpretation should be paid to the Tc-99m MIBI thyroid scan when differentiating malignant TN.


26 September 2018 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
YJYun Kyung Jeon
Yun Kyung Jeon
IKIn-Joo Kim
In-Joo Kim
KKKeunyoung Kim
Keunyoung Kim
Yun Kyung Jeon, In-Joo Kim, Keunyoung Kim; Reply to a Letter to the Editor: “Evaluation of bone mineral density using DXA and central QCT in postmenopausal pat

1 August 2012 in Proceedings of the International Astronomical Union
Verified
Journal Article
Open access
PDF file
YLYu-Chi Lee
Yu-Chi Lee
YKY Kim
Y Kim
HKHyun-Jae Kang
Hyun-Jae Kang
JJJoon‐Yong Jung
Joon‐Yong Jung
CLC Lee
C Lee
RDRoger L. Davies
Roger L. Davies

3 December 2025 in Human Brain Mapping
Verified
Journal Article
Open access
KPKyoungjune Pak
Kyoungjune Pak
JKJihyun Kim
Jihyun Kim
KKKeunyoung Kim
Keunyoung Kim
SSSeongho Seo
Seongho Seo
MLMyung-jun Lee
Myung-jun Lee
The dopamine transporter (DAT) mediates the reuptake of extracellular dopamine into presynaptic neurons. We investigated the effects of glucose loading on the striatal DAT in healthy young adults who underwent 18 F‐FP‐CIT PET scans and completed a sweet taste questionnaire (STQ). Thirty‐five healthy participants were enrolled in this study. Each participant visited the institution three times for three brain PET scans (two 18 F‐FP‐CIT PET scans after the infusion of glucose or placebo and one 18 F‐Fluorodeoxyglucose PET scan). All participants underwent the 12‐item self‐reporting STQ to evaluate their reactions to eating sweet foods, cravings for sweet foods, and degree of control over eating sweet foods (STQ 1: sensitivity to the mood‐altering effect of sweet foods, and STQ 2: impaired control over eating sweet foods). In the caudate, glucose‐loaded DAT availability was significantly higher than placebo‐loaded DAT availability, and in the putamen, there was a trend toward higher DAT availability following glucose loading. The STQ was consistently positively related to glucose‐loaded DAT availability, not with placebo‐loaded DAT availability. In conclusion, changes in striatal DAT availability after glucose loading suggest an association with attitudes toward sweet foods in healthy young males. This may indicate that individuals with higher DAT availability after glucose loading experience rapid clearance of synaptic dopamine after consuming sweet foods, potentially leading to a desire for additional sweet foods.